Commitments and Contingencies Royalties (Details) (USD $)		12 Months Ended
	Dec. 22, 2006 Convertible Debt [Member]	Dec. 31, 2012 Bio Mimetics [Member]	Dec. 31, 2011 Bio Mimetics [Member]	Dec. 31, 2010 Bio Mimetics [Member]	Dec. 31, 1991 Bio Mimetics [Member]	Dec. 31, 1989 Bio Mimetics [Member]	Sep. 30, 2010 Bio Mimetics [Member]	Dec. 31, 1989 Bio Mimetics [Member] Net Sales Based On BDS [Member]	Dec. 31, 1989 Bio Mimetics [Member] Net Sales Based On Assets [Member]	Dec. 31, 1989 Bio Mimetics [Member] Convertible Debt [Member]
Business Acquisition [Line Items]
Business acquisition, cost of acquired entity, purchase price						$ 2,600,000
Notes payable interest accrual rate	8.00%									9.00%
Stock issued during period, shares, conversion of convertible securities					500,000
Business Acquisition, Cost of Acquired Entity, Cash Paid					100,000
Royalty percentage of net sales						2.00%
Maximum Aggregate Monetary Amount Recieved Per Royalty Agreement								7,500,000	7,500,000
Maximum Range In Years of Royalty Agreement						0 years
Conditional Royalty Reduction Percentage						25.00%
Royalty Agreement Maximum Conditional Stock Price						$ 20
Royalty expense		0	0	31,546
Reserve for losses and loss adjustment expenses							2,200,000
Payments for legal settlements				$ 1,800,000